Sofiya Latifyan
Centre Hospitalier Universitaire Vaudois · 63 works · 3,186 citations · h-index 14
Top works
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy
- Targeting immune checkpoints in breast cancer: an update of early results
- 68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
- Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis
- Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series
- Bisphosphonate-related osteonecrosis of the jaw: a review of the potential efficacy of low-level laser therapy
- Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events
- Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study
- Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
- Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma
- Mucosal Melanoma of the Head and Neck: A Retrospective Review and Current Opinion
- 2022-RA-1349-ESGO Treated as a skin carcinoma: recurrent, metastatic squamous cell carcinoma from a degenerated mature teratoma of the ovary
- Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy
- Cancer Care of Children, Adolescents and Adults With Autism Spectrum Disorders: Key Information and Strategies for Oncology Teams
- Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors
- Tumor-reactive clonotype dynamics underlying clinical response to TIL therapy in melanoma
- Use of low-level laser therapy (LLLT) or photobiomodulation (PBM) for the management of the hand-foot syndrome (HSF) or palmo-plantar erythrodysesthesia (PPED) associated with cancer therapy
- Tumour-associated osteomalacia and hypoglycaemia in a patient with prostate cancer: is Klotho involved?
- Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy